Kymera Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
500 North Beacon Street, 4 Th Floor, Watertown, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
10/31/2024, 07:47 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report KYMERA THERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report Feb 12, 2024
SC 13G/A Report Feb 12, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report SEC SCHEDULE 13G Feb 8, 2024
SC 13G/A Report Jan 29, 2024
SC 13G/A Report Jan 23, 2024
SC 13G/A Report SC 13G/A Jan 10, 2024
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G Report SC 13G Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G Report KYMERA THERAPEUTICS, INC. Feb 14, 2023
SC 13G/A Report SCHEDULE 13G/A Feb 9, 2023
SC 13G Report Feb 8, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13G/A Report Feb 1, 2023
SC 13G/A Report Jul 11, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2022
SC 13G Report Feb 14, 2022
SC 13G/A Report AMENDMENT TO SC 13G Feb 11, 2022
SC 13G Report SCHEDULE 13G Feb 10, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report Feb 4, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Feb 16, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G Report Feb 8, 2021